Company: TELO
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-023970
Chunk: 41

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 8
Chunk 41
---
 estimated on the grant date using the Black-Scholes valuation model that uses assumptions for expected
volatility, expected dividends, expected term, and the risk-free interest rate. Expected price volatility is based on the historical
volatilities of a peer group as the Company does not have a multi-year trading history for its shares. Industry peers consist of several
public companies in the biotech industry similar to the Company in size, stage of life cycle and product indications. The Company intends
to continue to consistently apply this process using the same or similar public companies until a sufficient amount of historical information
regarding the volatility of the Company’s own stock price becomes available, or unless circumstances change such that the identified
companies are no longer similar to the Company, in which case, more suitable companies whose share prices are publicly available would
be utilized in the calculation.

Expected
term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of
the vesting term plus contract term. The risk-free rate is based on the 5-year U.S. Treasury yield curve in effect at the time of grant.
The Company recognizes forfeitures as they occur.

The
following is option activity during the six months ended June 30, 2025.

 Schedule
of option activity

    Number of Shares  
    Weighted Average Exercise Price Per Share  
    Weighted Average Remaining Contractual Life (Years)  
    Aggregate Intrinsic Value 
  
    Outstanding as December 31, 2024 
     2,352,670  
    $5.02  
     9.6  
    $- 
  
    Options granted 
     2,050,000  
    $2.12  
     -  
    $- 
  
    Expired 
     (12,500) 
    $5.02  
     -  
    $- 
  
    Forfeitures 
     (150,000) 
    $5.02  
     -  
    $- 
  
    Outstanding as June 30, 2025 
     4,240,170  
    $3.62  
     9.4  
    $- 
  
    Exercisable, June 30, 2025 
     4,073,920  
    $3.61  
     9.4  
    $-